Your browser doesn't support javascript.
loading
The high frequency of anti-PF4/heparin antibodies in patients with COVID-19 is neither related to heparin treatment or to an increased incidence of thrombosis.
Pascreau, Tiffany; Ballester, Marie-Christine; Van Dreden, Patrick; Zia-Chahabi, Sara; Zuber, Benjamin; Choucair, Jad; Bironien, Roselyne; Farfour, Eric; Vasse, Marc.
  • Pascreau T; Department of Clinical Biology, Foch Hospital, Suresnes, France.
  • Ballester MC; INSERM UMR_S 1176, University Paris-Sud, University Paris-Saclay, Le Kremlin-Bicêtre, France.
  • Van Dreden P; Emergency Unit, Foch hospital, Suresnes, France.
  • Zia-Chahabi S; R&D, Diagnostica Stago, Gennevilliers, France.
  • Zuber B; Department of Clinical Biology, Foch Hospital, Suresnes, France.
  • Choucair J; Department of Medical and Surgical Intensive Care Unit, Foch Hospital, Suresnes, France.
  • Bironien R; Pneumology Department, Foch Hospital, Suresnes, France.
  • Farfour E; Department of Clinical Biology, Foch Hospital, Suresnes, France.
  • Vasse M; Department of Clinical Biology, Foch Hospital, Suresnes, France.
Clin Chem Lab Med ; 59(11): e405-e408, 2021 10 26.
Article en En | MEDLINE | ID: mdl-34187132

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trombosis / Factor Plaquetario 4 / Heparina / SARS-CoV-2 / Tratamiento Farmacológico de COVID-19 / Anticuerpos Tipo de estudio: Incidence_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2021 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trombosis / Factor Plaquetario 4 / Heparina / SARS-CoV-2 / Tratamiento Farmacológico de COVID-19 / Anticuerpos Tipo de estudio: Incidence_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2021 Tipo del documento: Article